Novel therapies in low- and high-risk myelodysplastic syndrome

Ulrich Germing,Thomas Schroeder,Jennifer Kaivers,Andrea Kündgen,Guido Kobbe,Norbert Gattermann

Novel therapies in low- and high-risk myelodysplastic syndrome

2019

Ulrich Germing
Thomas Schroeder
Jennifer Kaivers
Andrea Kündgen
Guido Kobbe
Norbert Gattermann

ABSTRACTIntroduction: Myelodysplastic syndromes (MDS) comprise a heterogeneous group of myeloid neoplasms with diverse clinical courses. The revised version of the international prognostic scoring ...

Keywords:

Myeloid
Diabetes mellitus
Medicine
Myelodysplastic syndromes
Immunology
Oncology
Investigational Drugs
Internal medicine
heterogeneous group

Correction
Source
Cite
Save
Machine Reading By IdeaReader

109

References

Citations